SCHEMBL25927666

SCHEMBL25927666

OC(O)c1c[nH]c2cc(F)c(Br)c(F)c12

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31386176 0.74 GPR84 (0.35) GPR84
SCHEMBL31748699 0.72 GPR84 (0.34) GPR84
SCHEMBL25331893 0.72 PRKAG1 (0.50) —
SCHEMBL31748637 0.71 GPR84 (0.31) GPR84
SCHEMBL31748517 0.70 CHUK (0.38) GPR84
SCHEMBL15300768 0.70 CYP2A6 (0.46) GPR84
SCHEMBL22438703 0.70 GPR84 (0.45) GPR84
SCHEMBL31748680 0.65 — —
SCHEMBL25331903 0.65 NR4A2 (0.37) —
SCHEMBL30469079 0.65 NR4A2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023147312-A1 AMPK AGONISTS AND METHODS OF USE THEREOF EVVIA THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback